** Drugmaker Radius Health's shares RDUS.O rise ~13.5% to
$10.11
** Co enters definitive agreement to be acquired by Gurnet
Point Capital and Patient Square Capital in a deal valued at
about $890 mln urn:newsml:reuters.com:*:nGNX9HS4Hk
** Under terms of deal, entity jointly owned by Gurnet and
Patient Square will acquire all outstanding shares of RDUS for
$11/shr, implying a premium of 23.4% to stock's last close
** Upon completion of deal, which is expected in Q3, RDUS
will become a private company
** RDUS up ~47% YTD
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))